ASTREX Trademark

Trademark Overview

On Wednesday, September 15, 2021, a trademark application was filed for ASTREX with the United States Patent and Trademark Office. The USPTO has given the ASTREX trademark a serial number of 97028779. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, September 12, 2024. This trademark is owned by Astrex Medical Products, LLC. The ASTREX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

design of fluid delivery related health care products, namely, infusion pumps
astrex

General Information

Serial Number97028779
Word MarkASTREX
Filing DateWednesday, September 15, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, September 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements

Goods and Servicesdesign of fluid delivery related health care products, namely, infusion pumps

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 21, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstrex Medical Products, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWixom, MI 48353
Party NameAstrex Medical Products, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWixom, MI 48353

Trademark Events

Event DateEvent Description
Saturday, September 18, 2021NEW APPLICATION ENTERED
Thursday, October 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 17, 2022ASSIGNED TO EXAMINER
Friday, July 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, July 17, 2022NON-FINAL ACTION WRITTEN
Sunday, July 17, 2022NON-FINAL ACTION E-MAILED
Sunday, July 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 19, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 30, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 30, 2023SOU EXTENSION 2 FILED
Wednesday, August 30, 2023SOU EXTENSION 2 GRANTED
Friday, September 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 19, 2023SOU EXTENSION 1 FILED
Wednesday, April 19, 2023SOU EXTENSION 1 GRANTED
Friday, April 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 13, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 12, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 12, 2024SOU EXTENSION 4 GRANTED
Thursday, September 12, 2024SOU EXTENSION 4 FILED
Tuesday, May 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 13, 2024SOU EXTENSION 3 GRANTED
Monday, May 13, 2024SOU EXTENSION 3 FILED

Related Keywords

astrex products namely infusion pumps care health fluid delivery related design